Stem cell start-ups iZumi Bio and Pierian merge into iPierian
08 July 2009
Asher Mullard
Please Login to read the full article.
08 July 2009
Asher Mullard
asher.mullard@informa.com
iZumi Bio and Pierian, two start-ups working with induced pluripotent stem (iPS) cells, have merged into iPierian. The new company plans to use induced pluripotent stem (iPS) cells – which can potentially be used to generate new models of genetic diseases – primarily for drug discovery.
"Our...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US grants iPS cell patent to Japanese university pioneer
- US Capitol Capsule: Court rulings in gene patent, stem cell cases provide new hope for biopharma
- Panic! No, don't panic! ECJ embryonic stem cells ruling divides opinion
- Dainippon Sumitomo taps the potential of iPS cells for rare disease research
COMMENT
Other Informa Comment
EVENTS
09 February 2012
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
